NRXS · AMEX
Neuraxis (NRXS) Stock Price & Fundamentals
Neuraxis (NRXS) closed at $1,137.75 on Oct 9, 2026, up 0.10% from the previous close of $1,136.59.
Share price, past year
1Y +18.66%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,137.75 |
| Sep 30, 2026 | $1,149.54 |
| Aug 31, 2026 | $1,188.53 |
| Jul 31, 2026 | $1,135.16 |
| Jun 30, 2026 | $1,052.38 |
| May 29, 2026 | $1,046.30 |
| Apr 30, 2026 | $1,097.12 |
| Mar 31, 2026 | $1,079.39 |
| Feb 27, 2026 | $1,004.66 |
| Jan 30, 2026 | $1,006.64 |
| Dec 31, 2025 | $975.04 |
| Nov 28, 2025 | $955.72 |
| Oct 31, 2025 | $960.83 |
Key statistics
- Market cap
- $14.19B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.77
- Revenue (TTM)
- $5.32M
- Net income (TTM)
- −$7.68M
- Shares outstanding
- 12.5M
- Dividend yield
- —
- 52-week range
- $938.96 – $1,208.02
Neuraxis's market cap is $14.19B, based on a share price of $1,137.75 and 12.5M shares outstanding as of Jun 30, 2026.
Financials
Neuraxis reported revenue of $3.57M for fiscal 2025, up 32.89% from fiscal 2024.
Neuraxis reported a net loss of $7.80M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $3.57M | +32.9% | −$7.80M | −218.6% | −$0.95 | −$6.46M |
| FY2024ended Dec 31, 2024 | $2.69M | +9.2% | −$8.24M | −306.8% | −$1.22 | −$6.13M |
| FY2023ended Dec 31, 2023 | $2.46M | −8.4% | −$14.63M | −594.6% | −$4.50 | −$6.72M |
| FY2022ended Dec 31, 2022 | $2.68M | — | −$4.78M | −178.1% | −$2.77 | −$2.30M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.93M | −$2.09M | −$0.19 |
| Q1 FY2026ended Mar 31, 2026 | $1.61M | −$1.76M | −$0.18 |
| Q4 FY2025ended Dec 31, 2025 | $968.13K | −$1.71M | −$0.16 |
| Q3 FY2025ended Sep 30, 2025 | $811.41K | −$2.12M | −$0.24 |
| Q2 FY2025ended Jun 30, 2025 | $894.09K | −$1.69M | −$0.22 |
| Q1 FY2025ended Mar 31, 2025 | $895.66K | −$2.28M | −$0.33 |
| Q4 FY2024ended Dec 31, 2024 | $761.17K | −$1.45M | −$0.23 |
| Q3 FY2024ended Sep 30, 2024 | $666.63K | −$1.76M | −$0.25 |
Company profile
- Name
- Neuraxis, INC
- Ticker
- NRXS
- Exchange
- AMEX
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 11611 N. Meridian St, Suite 330, Carmel, IN 46032
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001933567
Recent SEC filings
- Aug 19, 2026
- Aug 11, 2026
- Jul 10, 2026
- Jun 12, 2026
- May 12, 2026
- Apr 22, 2026
- Apr 21, 2026
- Mar 19, 2026
Frequently asked questions
What is Neuraxis's stock price?
Neuraxis (NRXS) closed at $1,137.75 on Oct 9, 2026, up 0.10% from the previous close of $1,136.59.
What is Neuraxis's market cap?
Neuraxis's market cap is $14.19B, based on a share price of $1,137.75 and 12.5M shares outstanding as of Jun 30, 2026.
How much revenue does Neuraxis make?
Neuraxis reported revenue of $3.57M for fiscal 2025, up 32.89% from fiscal 2024.
Does Neuraxis pay a dividend?
Neuraxis's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Neuraxis, INC's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures